| Revenue Growth | Modern Oral net sales up 103%; Zig-Zag down 15% to $37 million. |
|---|---|
| Mgmt Confidence | High confidence in Modern Oral strategy; cautious on Q4 timing uncertainties. |
| Demand Visibility | Strong consumer pull; tracking sales to wholesale and retail velocity metrics. |
| Margin Trends | Gross margin 56%; EBITDA down 41% due to high marketing investment. |
| Op. Leverage | Expect costs to be leveraged over larger revenue base as distribution scales. |
| Vol vs Price | Growth driven by brick-and-mortar distribution expansion and chain account wins. |
| Segment Growth | Modern Oral 49% of revenue; Stoker's MSP outperforming category; Zig-Zag stable. |
| New Clients | On track to increase chain store count by 70% in 2026. |
| Capex & Debt | $250 million cash; $10 million stock repurchased; $1-2 million Q4 capex. |
| Regulatory | Dual-tracking PMTA submissions; US manufacturing commencement expected in 2027. |
| Commentary | Investing heritage business cash flow to build leading brands in Modern Oral. |
| New Launches | Alp Frontier Collection and limited edition Free Labs flavors introduced. |
Growth
Consolidated net sales rose 27% to $151 million; Modern Oral grew 103%.
Outlook
Targeting 70% increase in chain store count by year-end 2026.
Risks
Management used vague language regarding Q4 guidance ranges and specific timing of chain rollouts.
The company's earnings call, NYSE: TPB, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Turning Point Brands, Inc.: key numbers
- Share price
- $49.67Close, Nov 16
- Market cap
- $988M
- Shares outstanding
- 19.88MLatest SEC cover page
- Sector
- Manufacturing
- Industry
- Tobacco ProductsSIC 2100
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Turning Point Brands, Inc.
All →Turning Point Brands Q3 2026 Results: Net Income $3.93M, Down 81.4% YoY
Turning Point Brands reported net sales of $151.1 million for the third quarter of 2026, a significant increase from $119.0 million in the prior year. However, operating income for the quarter fell to $9.9 million from $25.9 million due to a substantial rise in selling, general, and administrative expenses.
- Key figure
- Net income $3.93M · -81.4% YoY
Turning Point Brands Financial Results
Turning Point Brands reported third-quarter 2026 financial results, highlighted by a 27% increase in consolidated net sales to $151.1 million, driven by 102.9% growth in its Modern Oral business. Despite the revenue growth, net income fell 81.4% to $3.9 million as the company significantly increased sales and marketing investments to expand distribution for its nicotine pouch brands. The company reaffirmed its full-year 2026 guidance for Modern Oral sales and EBITDA.
- Term
- Q3 2026
“I have been involved with Turning Point Brands for nearly 14 years and have never been more optimistic about its future. I am very excited to serve as CEO at such an important time. I have tremendous confidence in our team, our brands and our strategy.”
David Glazek, Chief Executive Officer
“We delivered another quarter of strong results, highlighted by continued growth in Modern Oral and progress across our heritage brands. Our investments in FRE and ALP are expanding distribution, strengthening consumer engagement and positioning us to become a leading player in the rapidly growing nicotine pouch category.”
David Glazek, Chief Executive Officer
Turning Point Brands Leadership Change
Graham Purdy has resigned as President, CEO, and board member of Turning Point Brands for personal reasons, effective September 30, 2026. The company's Board of Directors has appointed current Executive Chairman David E. Glazek to succeed him as CEO, effective October 1, 2026.